Liver study tests drug processing in patients vs. healthy adults
NCT ID NCT06736223
First seen Jan 12, 2026 · Last updated May 07, 2026 · Updated 20 times
Summary
This study looked at how the body handles a single 50 mg dose of the drug ITF2357 in 24 adults with chronic liver impairment compared to those with normal liver function. The goal was to measure drug levels and safety, not to treat the liver condition. Participants took one oral dose and were monitored for side effects and drug breakdown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biotrial
Rennes, 35042, France
-
MC COMAC Medical Ltd
Sofia, 1606, Bulgaria
-
MC COMAC Medical Ltd
Sofia, 1612, Bulgaria
Conditions
Explore the condition pages connected to this study.